Discontinuation report AMARYL
Report ID | 51269 |
Drug Identification Number | 02245274 |
Brand name | AMARYL |
Common or Proper name | Amaryl 4mg |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GLIMEPIRIDE |
Strength(s) | 4MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-06-01 |
Actual discontinuation date | 2018-06-07 |
Remaining supply date | 2018-06-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-06-04 | English | Compare |
v2 | 2018-06-04 | French | Compare |
v3 | 2018-06-12 | English | Compare |
v4 | 2018-06-12 | French | Compare |
Showing 1 to 4 of 4